Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range

Clin Oral Implants Res. 2000 Aug;11(4):334-44. doi: 10.1034/j.1600-0501.2000.011004334.x.

Abstract

We evaluated the bone augmenting capacity of bioactive glass particles, size range 300-355 microns (BG-particles), in human sinus floor elevations using histomorphometrical methods. A total of 10 patients underwent bilateral grafting, using a 1:1 mixture of autogenous bone particles (from iliac crest) and BG-particles at one side (experimental side), and bone particles only at the other side (control side, split mouth design). A total of 72 bone biopsies were taken at the time of fixture installation; that is, 3 patients at 4 months, 3 at 5 months and 3 at 6 months after grafting and 1 patient at 16 months (when she presented again). In each case 6 biopsies were taken, 3 left and 3 right. Histomorphometry showed that in grafts at control sides, trabecular bone was present after 4 months, comprising almost 41% of the tissue volume. This bone contained viable osteocytes and was of mature lamellar type and showed a mature histological appearance. Bone volume continued to increase slightly, to 42% at 5 months, 44% at 6 months and 45% at 16 months. The graft volume at experimental sides consisted at 4 months for 28% of woven and some lamellar bone, and increased to 35% at 5 months and 38% at 6 months, when mainly lamellar bone was found. At 16 months a lamellar bone volume of 45% was found. The BG-particles transformed and became excavated with time, starting at 4 months, and their centers gradually filled with bone tissue. All BG-particles had disappeared by resorption at 16 months after grafting and had been replaced by bone tissue. Parameters of bone turnover (% osteoid surface, % resorption surface, mineral apposition rate as measured by tetracycline labeling) indicated that bone remodeling was very active at both sides, during more than 6 months, despite the mature histological appearance of the bone tissue. From these histological observations, we conclude that a 1:1 mixture of autogenous bone/BG-particles seems a promising alternative to autogenous bone only, when low amounts of bone tissue are available for sinus augmentation.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / therapeutic use*
  • Biopsy
  • Bone Matrix / pathology
  • Bone Remodeling / physiology
  • Bone Resorption / pathology
  • Bone Substitutes / chemistry
  • Bone Substitutes / therapeutic use*
  • Bone Transplantation* / methods
  • Dental Implantation, Endosseous
  • Dental Implants
  • Female
  • Fluorescent Dyes
  • Follow-Up Studies
  • Glass / chemistry*
  • Humans
  • Jaw, Edentulous / surgery
  • Maxilla / surgery
  • Maxillary Sinus / pathology
  • Maxillary Sinus / surgery*
  • Middle Aged
  • Osteocytes / pathology
  • Osteogenesis / physiology
  • Tetracycline

Substances

  • Biocompatible Materials
  • Biogran
  • Bone Substitutes
  • Dental Implants
  • Fluorescent Dyes
  • Tetracycline